Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hochhauser

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|November 1, 1995
Transfection of wild-type but not mutant p53 induces early monocytic differentiation in HL60 cells and increases their sensitivity to stressD Banerjee, H J Lenz, B Schnieders, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 24, 2020
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upG Argilés, J Tabernero, R Labianca, et al.
British Journal of Cancer|June 26, 2008
Alpha-fetoprotein and human chorionic gonadotrophin-beta as prognostic markers in neuroendocrine tumour patientsT Shah, R Srirajaskanthan, M Bhogal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2002
Phase II study of anti-gastrin-17 antibodies, raised to G17DT, in advanced pancreatic cancerB T Brett, S C Smith, C V Bouvier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Restoration of wild-type p53 activity in p53-null HL-60 cells confers multidrug sensitivityJ F Ju, D Banerjee, H J Lenz, et al.
British Journal of Cancer|March 2, 2013
A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinomaT Meyer, A Kirkwood, M Roughton, et al.
British Journal of Cancer|March 18, 2010
Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumoursN C Turner, S J Strauss, D Sarker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: a phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancerA D Seidman, D Hochhauser, M Gollub, et al.
British Journal of Cancer|September 19, 2002
A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumoursR J Francis, S K Sharma, C Springer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 29, 2019
Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparibP Hammel, H L Kindler, M Reni, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|November 1, 1995
Transfection of wild-type but not mutant p53 induces early monocytic differentiation in HL60 cells and increases their sensitivity to stressD Banerjee, H J Lenz, B Schnieders, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 24, 2020
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upG Argilés, J Tabernero, R Labianca, et al.
British Journal of Cancer|June 26, 2008
Alpha-fetoprotein and human chorionic gonadotrophin-beta as prognostic markers in neuroendocrine tumour patientsT Shah, R Srirajaskanthan, M Bhogal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2002
Phase II study of anti-gastrin-17 antibodies, raised to G17DT, in advanced pancreatic cancerB T Brett, S C Smith, C V Bouvier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Restoration of wild-type p53 activity in p53-null HL-60 cells confers multidrug sensitivityJ F Ju, D Banerjee, H J Lenz, et al.
British Journal of Cancer|March 2, 2013
A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinomaT Meyer, A Kirkwood, M Roughton, et al.
British Journal of Cancer|March 18, 2010
Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumoursN C Turner, S J Strauss, D Sarker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: a phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancerA D Seidman, D Hochhauser, M Gollub, et al.
British Journal of Cancer|September 19, 2002
A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumoursR J Francis, S K Sharma, C Springer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 29, 2019
Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparibP Hammel, H L Kindler, M Reni, et al.
Pageof 5